• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenotech Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Sun Pharma
  • BSE Code : 7341.0
  • ISIN : INE486F01012
57.61 1 (1.62%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    56.04

  • Today’s High

    58.50

  • Open

    57.46

  • Perv Close

    56.69

  • 52W Low

    51.00

  • 52W High

    107.79

Key Indicators

  • P/E(TTM)

    84.72

  • Mar.Cap (₹Cr.)

    351.60

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.75

  • Debt-Equity Ratio

    1.62

  • AGM Date

    01-Aug-2025

  • EPS

    0.68

  • P/E Ratio

    84.72

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    351.60

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    61.03

  • BV (₹)

    15.80

  • Sales( ₹ in Cr.)

    43.05

  • NP (in Cr.)

    4.50

  • NP Var(%)

    -46.0

  • Div%

    0.0

  • CPS (₹)

    1.90

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    351.60

  • 52 Week High

    107.79

  • 52 Week Low

    51.00

  • Price BSE

    58.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    351.60

  • P/C Ratio

    30.90

  • P/E Ratio

    78.70

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 43.05 40.83 42.42 36.57 22.45 26.02
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 43.05 40.83 42.42 36.57 22.45 26.02
Other Income 3.47 1.00 1.08 0.63 0.41 7.54
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 46.52 41.83 43.50 37.20 22.86 33.56
EXPENDITURE :            
Raw Materials 0.84 0.00 0.06 0.00 0.03 0.50
Power and Fuel Cost 2.71 2.69 3.79 3.25 3.12 3.29
Employee Cost 12.38 9.46 7.88 7.10 6.49 5.76
Other Manufacturing Expenses 9.52 8.70 7.67 6.66 4.67 5.61
Selling and Administration Expenses 2.85 2.33 2.00 1.91 1.62 1.75
Miscellaneous Expenses 0.57 0.43 0.31 0.19 0.13 0.12
Employee Benefit Expenses 12.38 9.46 7.88 7.10 6.49 5.76
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 28.87 23.61 21.72 19.10 16.06 17.04
Operating Profit 17.65 18.23 21.79 18.09 6.79 16.52
Interest 0.00 0.00 0.11 1.22 1.55 0.89
Gross Profit 17.65 18.23 21.68 16.87 5.24 15.63
Depreciation 6.96 7.09 7.17 6.97 6.46 4.85
Profit Before Tax 10.69 11.14 14.51 9.90 -1.22 10.78
Current Tax 2.49 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.59 2.84 2.92 -12.27 0.00 0.00
Reported Net Profit 5.61 8.30 11.59 22.18 -1.22 10.78
Extraordinary Items 1.12 -0.03 0.03 0.00 0.00 6.37
Adjusted Net Profit 4.49 8.33 11.56 22.18 -1.22 4.41
Adjustment below Net Profit -0.02 -0.03 0.04 0.06 -0.01 -0.05
P & L Balance brought forward -180.03 -188.30 -199.93 -222.17 -220.94 -231.68
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -174.44 -180.03 -188.30 -199.93 -222.17 -220.94
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.92 1.36 1.90 3.63 -0.20 1.77
Earnings Per Share(Adj)-Unit Curr 0.92 1.36 1.90 3.63 -0.20 1.77
Book Value 15.75 14.84 13.48 11.57 7.93 8.13
Book Value(Adj)-Unit Curr 15.75 14.84 13.48 11.57 7.93 8.13

Shareholding Pattern

  • Promoter Group

    68.84%

  • Public Share Holding

    31.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 42,014,578 68.84 42,014,578 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 42,014,578 68.84 42,014,578 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 600,000 0.98 600,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,364 0.01 4,364 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 604,364 0.99 604,364 2
2] Non Institution
Bodies Corporate 2,665,944 4.37 2,665,944 64
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 205,534 0.34 198,066 115
Foreign Non Institution Other 692,791 1.14 0 1
Hindu Undivided Families 942,586 1.54 942,586 277
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,217,795 15.10 4,124,557 50
Individuals holding nominal share capital up to Rs. 1 lakh 4,686,875 7.68 4,644,883 10,150
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 101 0.00 100 1
Sub Total 18,411,626 30.17 12,576,136 10,658
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,030,568 100.00 55,195,078 10,661

Company Background

Zenotech Laboratories LtdPharmaceuticals - Indian - Formulations

  • Zenotech Laboratories Ltd
  • BSE Code : 7341.0
  • ISIN : INE486F01012

  • Incorporation Year

    1989

  • Registered Office

    S No 250-252 Turkapally Villag
    Shameerpet Mandal RR District, Hyderabad,
    Telangana-500078

  • Telephone

    91-40-23480430/0435

  • FAX

    91-40-23480429

  • Chairman

    Azadar Hussain Khan

  • Managing Director

  • Company Secretary

    Abdul Gafoor Mohammad

  • Auditor

    PKF Sridhar & Santhanam LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Zenotech Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenotech Lab. 57.61 44.60 43.05 66.99 3.21
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10